跳至主要内容
临床试验/CTRI/2018/07/015113
CTRI/2018/07/015113招募中1 期

Total Lymphoid Irradiation as Salvage therapy in Refractory/Relapsed Lymphoma - TLI

Tata Memorial Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.all cases of relapsed / refractory Hodgkinâ??s or Non-Hodgkinâ??s lymphoma
  • 2. aged less than 70 yrs, have failed standard first line therapy and have been deemed unfit for ASCT and/or Aggressive salvage regimens due to poor general condition, unable to afford chemotherapy and/or ASCT, found unfit for any form of chemotherapy or unwilling for chemotherapy; but amenable to follow up with
  • acceptable laboratory parameters and informed consent taken.
  • Most of these cases would otherwise be deemed palliative/best supportive care.

排除标准

  • 1. KPS score of less than 60
  • 2. lab parameters (Hbless than 8gm/dl, Platelets less than 50,000/ml,
  • ANC less than 1000/mm3) 3.
  • unwilling for RT and RT contraindications such as hypersensitivity and collagen vascular disorders.

研究者

相似试验